TY - JOUR T1 - Current attitudes towards HIV viral load self-testing: thematic analysis of a consultation with potential end-users JF - medRxiv DO - 10.1101/2021.08.27.21260566 SP - 2021.08.27.21260566 AU - Harriet D Gliddon AU - Rachel A McKendry AU - Jo Gibbs Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/08/29/2021.08.27.21260566.abstract N2 - Background HIV viral load (VL) is key to monitoring response to antiretroviral therapy. A number of point-of-care HIV VL tests are in development. These tests could be repurposed for HIV VL self-testing.Methods We held a patient and public involvement (PPI) consultation for people living with HIV to explore the prospect of HIV viral load self-testing. We conducted a thematic analysis on the data from this consultation.Results Key themes were access, convenience, usability, technical aspects, technology potential, connectivity and confidentiality. Attendees expressed significant appetite for decentralised HIV care, including HIV VL self-testing.Conclusions This PPI consultation can help researchers developing HIV viral load self-testing technology to better understand the needs of potential end users. Our findings will help guide the development and implementation of HIV VL self-testing.Competing Interest StatementThe authors have declared no competing interest.Funding StatementHDG and RAM are funded by the iā€sense EPSRC IRC in Early Warning Sensing Systems in Infectious Disease (EP/K031953/1) and i-sense: EPSRC IRC Next Steps Award in Agile Early Warning Sensing Systems for Infectious Diseases and Antimicrobial Resistance (EP/R00529X/1). RAM acknowledges the Royal Society Wolfson Research Merit Award. The workshop was funded by a UCLH NIHR BRC Patient and Public Involvement Starter Grant.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UCL Research Ethics Committee (REC) Joint Chairs are in agreement that this work is exempt from the requirement to seek ethics review through the UCL REC.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available in the Supplemental Material. ER -